Evidence-Based Methods to Reduce Medications in Older Patients

Slides:



Advertisements
Similar presentations
UGA Doctor of Pharmacy Candidate
Advertisements

John N. Lavis, MD, PhD Professor and Canada Research Chair in Knowledge Transfer and Exchange McMaster University Program in Policy Decision-Making McMaster.
Drug appropriateness criteria: potential for indications creep Amy Lodolce, PharmD, BCPS Mike Koronkowski, PharmD.
Edward P. Sloan, MD, MPH, FACEP Conducting Successful EM Resident Research: Working with Databases.
Inpatient Palliative Care: What is it and Why it’s Important Lyra Sihra MD Associate Medical Director Gentiva Hospice.
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Meredith Cook Mercer COPHS August, Beers Criteria AGS and interdisciplinary panel of 11 experts in geriatrics and pharmacotherapy 53 medications.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Medication Reconciliation in Continuing Care Getting It Right Together Creating a Culture of Safety September 8, 2008 Dr. Paula Creighton MD, FRCP(C) Geriatric.
UMMS CRIT Module II: Drug Therapy in the Elderly Jerry H. Gurwitz, MD Chief, Division of Geriatric Medicine University of Massachusetts Medical School.
Optimal Pain Management for ED Patients: Issues in 2004 Edward P. Sloan, MD, MPH, FACEP Professor Department of Emergency Medicine University of Illinois.
Readmission and Chronic illness that could benefit from end of life discussions.
Medication Management. Medications and You Know your medications and how to take them.
American Society of Consultant Pharmacists America’s Senior Care Pharmacists® Principles of Drug Use: Prescribing for the Elderly Thomas R. Clark, RPh,
Drug safety in the elderly EFNS Stockholm 2012 Barbro Westerholm Prof.em, Member of Swedish Parliament.
Becoming an Activated Patient – Part 2
Cases – Medication Management Kenneth Brummel-Smith, MD Mariana Dangiolo, MD Copyright 2008, Florida State University College of Medicine. This work was.
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
Copyright © 2009 by The McGraw-Hill Companies, Inc. All Rights Reserved. McGraw-Hill Chapter 4 Electronic Health Records in the Hospital Electronic Health.
Polypharmacy and preventing hospital admissions
Polypharmacy May 2008 CRIT Heidi Auerbach, MD Copyright Boston University Medical Center.
Pharmacist’s Role in Transitions of Care
Becoming an Activated Patient – Part 1 Kenneth Brummel-Smith, MD Charlotte Edwards Maguire Professor of Geriatrics Florida State University College of.
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
Improving Value in Health Care: Challenges and Potential Strategies Arnold M Epstein October 24, 2008 Congressional Health Care Reform Education Project.
 Medication-related problems are common, costly and often preventable in older adults and lead to poor outcomes.
CONFIDENTIAL AND PROPRIETARY © 1998–2005 Epocrates, Inc. All rights reserved. Primary Care Physician (FP/IM) Survey Q
Preventing Errors in Medicine
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Making Wise Choices Kenneth Brummel-Smith, MD Charlotte Edwards Maguire Professor of Geriatrics Florida State University College of Medicine.
EVALUATING THE EFFECTIVENESS OF THE AGS UPDATED 2012 BEERS CRITERIA AS AN EDUCATIONAL TOOL IN A FAMILY MEDICINE RESIDENCY TRAINING PROGRAM Eseoghene Abokede.
Using an EHR Template and the Beer’s List to Address Geriatric Polypharmacy Rose Family Medicine Residency Emily Gutgsell, MD Emma Bjore, MD Anna Plunkett,
Grant Macdonald.  Appropriate polypharmacy describes treatment where a patient has multiple morbidities, and/or a complex condition, that is being managed.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Current Mental Health Care Systems
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
Continuity of Care in the Garden State
Palliative Care: Emergency Room Interaction
Clinical Pharmacists in General Practice
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Assoc. Prof. Martin Valis, M.D., Ph.D.
Copyright © 2007 American Medical Association. All rights reserved.
Ann Intern Med. 2014;160(11): doi: /M Figure Legend:
POLYPHARMACY IN GERIATRIC PATIENTS Dr SHREYAS MISTRY MD, Dr MAYUR RALI MD HOFSTRA-North Shore LIJ School of Medicine Department of Family Medicine Southside.
The Future Family Physician
Medication Reconciliation in Continuing Care
Clinical Pharmacy II.
Professor Colin P. Bradley University College Cork
Integrating Clinical Pharmacy into a wider health economy
HEDIS ® Measures & Tips: Behavioral Health
Value of Pharmaceuticals in Managed Care Pharmacy
HEALTH CARE SERVICES.
Polypharmacy In Adults: Small Test of Change
Does the Beer’s Criteria Influence Prescribing for Geriatric Patients?
Medications in Older Persons
Value of Pharmaceuticals in Managed Care Pharmacy
Value of Pharmaceuticals in Managed Care Pharmacy
Unit 1: Health Assisting
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Pharmacy practice experience I
MOCH (Medicines Optimisation in Care Homes) Pharmacists
Epidemiological Terms
8 Medication Errors and Prevention.
Frailty and Its Effect on the 4 M’s
COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE)
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Clinical Practice Guidelines: What, Why, Who?
Value of Pharmaceuticals in Managed Care Pharmacy
Pharmacy Integration Improving care in care homes
Presentation transcript:

Evidence-Based Methods to Reduce Medications in Older Patients Kenneth Brummel-Smith, MD Charlotte Edwards Maguire Professor of Geriatrics Florida State University College of Medicine Copyright 2007, Florida State University College of Medicine. This work was supported by a grant from the Donald W. Reynolds Foundation. All rights reserved.

Objectives Describe 5 factors to consider when discontinuing a medication Describe 3 initiatives physicians can take to lower medications Describe two initiatives patients can take to lower medications

One person’s drugs

Prevalence of the Problem Medication errors each year: 7000 deaths 95,000 hospital admissions 700,000 emergency visits 3,000,000 office visits 30% more money spent on treating errors than on medications themselves 5th most common cause of death in US IOM, To Err is Human, 2000

FM Residency Chart Review Epocrates Medication Check 17% - contradicted medication combination 42% - avoid use/alternative combination 78% - monitor/modify Treatment combination 64% - caution advised combination Beer’s List 44% of polypharmacy patients were on a Beer’s drug Of those on a Beer’s drug, 75% of patients were on a high risk drug Polypharmacy – 5 or more prescription drugs

Beer’s Drugs (High Severity) amitriptylene barbituates chlordiazepoxide chlorpropamide diazepam doxepin flurazepan hysocyamine meperidine methyldopa pentazocine ticlopidine Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997;157:1531-6.

Considering Appropriateness Remaining life expectancy Time until benefit Goals of care Treatment targets Cost “Indications to Discontinue” Holmes H, Arch Int Med, 2006

Remaining Life Expectancy Women Men Walter LC, JAMA, 2001

Time Until Benefit Short term benefits Long term benefits Analgesics for pain Sx relief Long term benefits Primary prevention Secondary prevention Different than number needed to treat More individualized

Goals of Care Shared decision making Changes as person ages Cure illness Prevent death Prevent disability Relieve suffering Increase function Promote health Prevent transmission Increased quality of life Increased control A good death Shared decision making Changes as person ages Changes as disease progresses

Treatment Targets Related to goals Goal = general Target = measurable outcome Positive targets (to reach) Negative targets (to avoid)

Costs Financial Impact on family Risk of adverse effects Costs: Aricept? Norvasc? Celebrex? Effexor?

Physician’s Control- Teach Your Students! Minimum 2 year wait on new drugs 7 year wait is safer Do not use drugs on the Beer’s list Use generics Use the 4 step approach to evaluate new and current drugs Use an EHR with: Medication decision support Computerized entry 73% of pts are satisfied with reductions Straand J, Fam Prac, 2001

Teach Your Patients Keep a list of your drugs – show it every visit Use only one pharmacy Don’t ask for any drug that is advertised on TV or in magazines Ask how long the drug has been on the market Don’t take any drug until it’s been out for at least 2 years Ask if there are other things besides taking a drug you can do Ask if you should stop any current drugs

Helpful Sites Therapeutics Initiative: Evidence Based Drug Therapy www.ti.ubc.ca Univ of British Columbia OHSU Drug Effectiveness Review Project www.ohsu.edu/drugeffectiveness